Landmark victory for individuals living with DEB and their families, the FDA announced their approval of Krystal Biotech’s VYJUVEK™ for the treatment of Dystrophic Epidermolysis Bullosa (DEB).

Nuggets coach blasts 'national narrative' spotlighting Lakers

Ukraine war: US to support providing F-16 fighter jets to Ukraine

Premier League predictions: Gameweek 37

8 Things You Might Not Know About 'The Joy Luck Club'

MLS News: San Diego announced as 30th MLS Team

DeSantis meets New Hampshire lawmakers, greets voters ahead of expected 2024 announcement

Inside the Clubhouse: 5 early MLB trade deadline candidates

Matty Healy already bonding with Taylor Swift’s family amid romance

Pay Transparency Laws: What Small Businesses Need to Know

Pac-12 Football: 5 incredibly early bold predictions for the 2023 season

XO, Kitty Has All The Charm Of To All The Boys — But It Digs Deeper